Get the Weekly Intelligence Brief — top committee picks every Sunday.

NVST vs RPRX

Envista Holdings vs Royalty Pharma plc — AI-powered side-by-side comparison
NVST
Envista Holdings
76
Strong Buy
VS
RPRX
Royalty Pharma plc
56
Watch
MetricNVSTRPRX
AI Score 76 56
Price $28.51 $57.79
P/E Ratio 48.34× 23.98×
ROE 1.5% 11.9%
Revenue Growth YoY
Gross Margin 55.5% 89.4%
Debt / Equity 0.52× 1.31×
Dividend Yield 0.0% 1.6%
RSI (14) 59.3 49.6
Beta 0.861 0.425
Expected Upside +1.4%

AI Committee View

Current Innellis committee reasoning for NVST versus RPRX.
NVST leads by 20 points.

NVST scores 76/100 (Strong Buy) versus RPRX at 56/100 (Watch).

NVST Committee View
100% agreement
4 analysts

The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.

Bull Case
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
Bear Case
  • Weekly trend is bearish while daily is bullish — against the higher-timeframe trend.
  • Risk/reward is unfavorable: 14.2% downside vs 1.4% upside.
RPRX Committee View
60% agreement
5 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Value Analyst remains cautious — p/e of 40.9 is expensive by classic value standards. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
  • Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
  • P/E of 40.9 is expensive by classic value standards — Value
  • EPS declining -15.9% YoY despite any revenue growth — Growth
  • MACD histogram negative -- bearish momentum — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
NVST Full Analysis RPRX Full Analysis